2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015/10/14 by Bryan R. Haugen, Erik K. Alexander, Keith C. Bible +13 · 37 citations
Medicine · #Thyroid Cancer Diagnosis and Treatment #Thyroid Disorders and Treatments #Thyroid and Parathyroid Surgery
paper · pdf · doi:10.1089/thy.2015.0020
openalex publication_date 2015/10/14 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
Abstract
BACKGROUND: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the American Thyroid Association's (ATA's) guidelines for the management of these disorders were revised in 2009, significant scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid nodules and differentiated thyroid cancer. METHODS: The specific clinical questions addressed in these guidelines were based on prior versions of the guidelines, stakeholder input, and input of task force members. Task force panel members were educated on knowledge synthesis methods, including electronic database searching, review and selection of relevant citations, and critical appraisal of selected studies. Published English language articles on adults were eligible for inclusion. The American College of Physicians Guideline Grading System was used for critical appraisal of evidence and grading strength of recommendations for therapeutic interventions. We developed a similarly formatted system to appraise the quality of such studies and resultant recommendations. The guideline panel had complete editorial independence from the ATA. Competing interests of guideline task force members were regularly updated, managed, and communicated to the ATA and task force members. RESULTS: The revised guidelines for the management of thyroid nodules include recommendations regarding initial evaluation, clinical and ultrasound criteria for fine-needle aspiration biopsy, interpretation of fine-needle aspiration biopsy results, use of molecular markers, and management of benign thyroid nodules. Recommendations regarding the initial management of thyroid cancer include those relating to screening for thyroid cancer, staging and risk assessment, surgical management, radioiodine remnant ablation and therapy, and thyrotropin suppression therapy using levothyroxine. Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using imaging and serum thyroglobulin, thyroid hormone therapy, management of recurrent and metastatic disease, consideration for clinical trials and targeted therapy, as well as directions for future research. CONCLUSIONS: We have developed evidence-based recommendations to inform clinical decision-making in the management of thyroid nodules and differentiated thyroid cancer. They represent, in our opinion, contemporary optimal care for patients with these disorders.
Citations
Cited by
- Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects
- First-in-Human Study of [ 211 At]NaAt as Targeted a-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial)
- Portable Multispectral Optoelectronic System for Thyroid Cancer Detection
- Somatic genetic alterations in the development and progression in thyroid tumors of follicular cells
- American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum
- Tumor size and presence of metastases in differentiated thyroid cancer: comparing cohorts from two countries
- Clinical characteristics and prognosis of histological subtypes of papillary thyroid carcinoma in pediatric patients
- Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma
- The 2017 Bethesda System for Reporting Thyroid Cytopathology
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- Malignancy Rate in Thyroid Nodules Classified as Bethesda Category III (AUS/FLUS)
- Thyroid Cancer Incidence and Mortality Trends in the United States: 2000–2018
- Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guideline Recommendations
- Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples
- Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell–Derived Thyroid Carcinomas
- Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma
- Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma
- Controversies, Consensus, and Collaboration in the Use of 131 I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association
- Reduced sensitivity to thyroid hormones is associated with differentiated thyroid cancer in the euthyroid thyroidectomy population
- Lenvatinib: Role in thyroid cancer and other solid tumors
- Long-Term Durability of Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer
- Clinical and treatment patterns of advanced and radioiodine-refractory differentiated thyroid cancer. ERUDIT study
- AI may help to predict thyroid nodule malignancy based on radiomics features from [18F]FDG PET/CT
- Thyroid hormones, mitochondria, aging, and cancer
- Reproductive risks and fertility preservation in women treated with radioactive iodine therapy for thyroid cancer
- Glucose Metabolic Reprogramming in Thyroid Cancer: Underlying Molecular Mechanisms and Links to Progression and Treatment
- Extracting Thyroid Nodules Characteristics from Ultrasound Reports Using Transformer-based Natural Language Processing Methods
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
- Adaptive Dual-Task Deep Learning for Automated Thyroid Cancer Triaging at Screening US
- Ultrasound risk stratification for malignancy using the 2015 American Thyroid Association Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
- Toward Reduction in False-Positive Thyroid Nodule Biopsies with a Deep Learning–based Risk Stratification System Using US Cine-Clip Images
- DNA-PKcs inhibition as a therapeutic approach for differentiated thyroid cancer
- Chronic Fatigue After Thyroidectomy: A Patient-Centered Survey
- Ultrasound Elastography Predicts Thyroid Nodule Volume Reduction Rate After Percutaneous Ethanol Ablation
- Active Surveillance for Pleomorphic Adenomas of the Parotid—Tumor Growth Rate, Potential Malignancy, and Surgical Sequalae
- Performance of contrast-enhanced ultrasound (CEUS) in assessing thyroid nodules: a systematic review and meta-analysis using histological standard of reference
- 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
- Long-term progression of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A single-center retrospective study of the French Marne–Ardennes thyroid cancer registry
- Recombinant TSH Performs as Well as Thyroid Hormone Withdrawal for Iodine-131 Therapy With Dosimetry for Thyroid Cancer
Related